Solid tumor oncology program

The solid tumor oncology team at Children’s Wisconsin in the MACC Fund Center for Cancer and Blood Disorders is comprised of pediatric oncologists and many collaborating sub-specialists required to provide complete care for any patients with a solid tumor diagnosis – both at initial diagnosis and at the time of relapse. Our solid tumor team cares for the most common solid tumor malignancies in children and adolescents, including: Wilms Tumor, Hepatoblastoma, Ewing Sarcoma, Osteosarcoma, Neuroblastoma, Retinoblastoma, Rhabdomyosarcoma, Langerhans’s Cell Histiocytosis. We are also established in providing care for the more uncommon diagnoses. We have close partnerships with pediatric surgeons, orthopedic oncology surgeons, radiation oncologists, pediatric urologists, pediatric liver specialists, pediatric transplant surgeons and pediatric endocrinologists. Because solid tumor oncology includes many unique diagnoses, our team approaches each patient as an individual. We evaluate every tumor with genetic sequencing to help inform how targeted therapies may be complementary to widely accepted standard of care treatments. Our team provides education and help with enrollment on appropriate clinical trials.

Our partnerships with many of our subspecialists are highlighted below.

Musculoskeletal oncology program

Musculoskeletal tumors form in the body's connective tissue, which includes bone and cartilage. Some of these tumors are malignant, which means they have the ability to spread to other parts of the body.

The most common types of malignant musculoskeletal cancer are osteosarcoma and Ewing sarcomas, which usually happen in children and teens. Care often includes surgery, radiation therapy and chemotherapy.

Our team works with orthopedic oncology surgeons and pediatric radiation oncologists to develop complete treatment plans from initial surgery through follow up and rehabilitation care. We collaborate with weekly patient discussions to ensure that the entire team is up to date on all of our patients.

Retinoblastoma program

Our solid tumor oncology team partners with the ocular oncology team to provide comprehensive care for patients with Retinoblastoma. Retinoblastoma is the most common cancer that occurs in the eye of infants and young children. More information about our program can be found here: (Insert link to RB program website)

Cancer predisposition program

While most new oncology diagnoses in children and adolescents are sporadic (meaning we don’t know why they have occurred), our solid tumor oncology team partners with the Cancer Predisposition Program at the MACC Fund Center for Cancer and Blood Disorders when needed. This ensures that any new solid tumor oncology patient with concern for a genetic cause for their tumor developing has access to this team for any needed genetic counseling or testing. More information about this program can be found here: (insert link to Cancer Predisposition Website).

COMPASS program

With increasing use of genetic testing of tumors, we partner with the COMPASS team at the MACC Fund Center for Cancer and Blood Disorders to help with interpretation of results and consideration for individualized targeted treatment for solid tumor patients. Our teams work together to determine which patients will benefit from consultation and ensure a seamless referral process. Find more information about Children's Wisconsin COMPASS Clinic.

Join the young adult oncology group
Young adults who have received or currently are receiving cancer treatment may need special support.

Get a second opinion
It's important to learn everything you can about your child’s diagnosis and care. We'll give you a second opinion.

Support for survivors and their families
How will a diagnosis or treatment for childhood cancer or a blood disorder affect your child's health and well-being in the future?